| Company News |
SIGA Technologies Reports Financial Results for the Second Quarter and First Half of 2010
SIGA Technologies
(August 05, 2010)
|
SIGA to Discuss Second Quarter Results of Operations on August 5, 2010
SIGA Technologies
(August 02, 2010)
|
EventAnalyzer: Daily Market Movers (25 Jun 2010)
(June 28, 2010)
|
Siga Completes Fourth Successful Human Safety Clinical Trial
SIGA Technologies
(June 23, 2010)
|
Andy Stern Joins SIGA's Board of Directors
SIGA Technologies
(June 21, 2010)
|
SIGA CEO Dr. Eric Rose Addresses Congressional Appropriations Subcommittee on Behalf of the Alliance for Biosecurity
SIGA Technologies
(May 12, 2010)
|
SIGA Technologies Reports Operating Results for the First Quarter of 2010
SIGA Technologies
(May 04, 2010)
|
SIGA to Discuss First Quarter Results of Operations on May 4, 2010
SIGA Technologies
(April 27, 2010)
|
SIGA Technologies Reports Financial Results for the Fourth Quarter and Full Year of 2009
SIGA Technologies
(March 10, 2010)
|
SIGA to Discuss Fourth Quarter and Year-End 2009 Results of Operations on March 10, 2010
SIGA Technologies
(March 05, 2010)
|
|
|
|
|
EvaluatePharma® - the premier source for pharma and biotech analysis.
Expert integration of financial and product data across historic and forecast timeframes (1986 to 2016) delivers a vast array of analytics by product, company, therapy area, EphMRA ATC code, technology, patent status, deals, license revenues and much more.
|
| Company Profile |
|
|
| Profile
|
SIGA Technologies (SIGA) is a New York based pharmaceutical company focused on the development & commercialisation of products for the prevention and treatment of serious infectious diseases, including products for use in defence against biological warfare agents. |
| Listed or Private Company
|
Listed |
| Company Classification
|
- |
| Company Website
|
Website
|
|
Full Company Profile Information
| EventAnalyzer - Last Key Event |
|
| Closing Price DateClosing Price Date
|
EventAnalyzer Note
|
Market Cap (US $m)
|
Change (%)
|
Change (+$m)
|
| 6/25/2010 |
25 Jun: Shares rise on 2.5x average daily trading volume. |
321 |
12.0% |
35 |
|
| EvaluatePharma® Coverage of Marketed and Pipeline Products |
|
|
| IN-DEPTH COMPETITIVE INTELLIGENCE AVAILABLE ON |
|
|
|
Register to access more FREE content:
- 2009 Product Sales analysis
- 2009 Pharmaceutical Sales
- 2009 Market Share & Global Ranking
- Download to Excel
- Search 2 yrs of company press releases
|
|
|
|